|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 239/42 |
| (11) | Patento numeris | 1633727 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04735910.4 |
| Europos patento paraiškos padavimo data | 2004-06-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-03-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-04-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2004/002373 |
| Data | 2004-06-03 |
| (87) | Numeris | WO 2004/108691 |
| Data | 2004-12-16 |
| (30) | Numeris | Data | Šalis |
| 0312896 | 2003-06-05 | GB | |
| 0324793 | 2003-10-24 | GB |
| (72) |
CRABB, Jeffrey Norman, GB
HORBURY, John, GB
TAYLOR, Nigel Philip, GB
|
| (73) |
AstraZeneca UK Limited,
15 Stanhope Gate, London, Greater London W1K 1LN,
GB
|
| (54) | IMPROVED PRODUCTION OF THE ROSUVASTATIN CALCIUM SALT |
| IMPROVED PRODUCTION OF THE ROSUVASTATIN CALCIUM SALT |